Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming. - Wikidata - wikimedia - TriplyDB

Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.

Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.

http://www.wikidata.org/entity/Q30499307

about

Nanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic Phenotype Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG)Nrf2, a regulator of the proteasome, controls self-renewal and pluripotency in human embryonic stem cells Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.Dynamic migration and cell-cell interactions of early reprogramming revealed by high-resolution time-lapse imaging.Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.GAA Deficiency in Pompe Disease Is Alleviated by Exon Inclusion in iPSC-Derived Skeletal Muscle Cells.Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells.miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2.High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells.Epigenetic characterization of the FMR1 promoter in induced pluripotent stem cells from human fibroblasts carrying an unmethylated full mutation A Comparative View on Human Somatic Cell Sources for iPSC Generation Induction of pluripotent stem cells from a cynomolgus monkey using a polycistronic simian immunodeficiency virus-based vector, differentiation toward functional cardiomyocytes, and generation of stably expressing reporter lines.Erythroid differentiation of human induced pluripotent stem cells is independent of donor cell type of origin.Novel codon-optimized mini-intronic plasmid for efficient, inexpensive, and xeno-free induction of pluripotency.Stable X chromosome reactivation in female human induced pluripotent stem cells FAS-based cell depletion facilitates the selective isolation of mouse induced pluripotent stem cells Retroviral vectors: post entry events and genomic alterations.An in vivo model of human small intestine using pluripotent stem cells Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology.Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model.Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction.Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation Reticular dysgenesis-associated AK2 protects hematopoietic stem and progenitor cell development from oxidative stress.Overcoming reprogramming resistance of Fanconi anemia cells.Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells TRIM32 modulates pluripotency entry and exit by directly regulating Oct4 stability Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model Overcoming Pluripotent Stem Cell Dependence on the Repair of Endogenous DNA Damage A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy.Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing.Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells.Molecular advances in reporter genes: the need to witness the function of stem cells in failing heart in vivo.Imaging of Induced Pluripotent Stem Cells: From Cellular Reprogramming to Transplantation.Concise review: managing genotoxicity in the therapeutic modification of stem cells.miRNAs involved in the generation, maintenance, and differentiation of pluripotent cells.The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.

P2860

Q26779454-7CDE9026-0839-434E-ACC9-32F68C2AFD77 Q27311626-8BD967E6-AA08-40E7-9B44-A24B7F618201 Q28394410-3E0D16D9-DB8D-47F2-BAC4-B5AF5B049364 Q29147385-9FF20496-70C5-4B20-8F3B-F5411370D9C0 Q30574663-F70B5C77-FCD4-4149-9414-193835129FB1 Q30618778-9FA66BF3-58CB-4ABE-9105-923D2F43B831 Q33587018-FA097856-13B9-4B39-91D9-174419AC2843 Q33635336-EC7235AB-18BE-4DD0-91A2-57EF4A0C6A11 Q33722582-47BA8680-07B4-4A63-99E0-44F2E3373CC3 Q33789907-E2A5E8AF-EFFE-4220-AB3E-A5D4C4E7680A Q34028395-4DFCC38A-561C-4154-842C-6BF11FA0D9F4 Q34261778-16FAB591-AEEB-4B11-BE4A-76475E6E43B5 Q34469474-8C03B7A0-6064-43F1-8391-EC6AF41FE20F Q34560769-C08982D5-A316-4AE0-90EC-8C6B617D0C07 Q34775239-2A90E062-FC71-4EE6-8E93-DFD79165264B Q34797997-8B0FE63A-A220-4A0A-824E-D88FBBA47BB0 Q35020560-3573BF6F-FE45-4F53-B193-5139E09CB274 Q35075314-86D57A8A-9BCC-4F33-B922-0C87F927AF4C Q35207724-99D2397B-C367-4A7E-A399-282FA8F90BFC Q35261336-13E48B91-214F-425A-AFB0-B288440E6A0C Q35533803-D7713731-CA09-4091-8889-22D63A4BEA16 Q35589803-529AFD22-5C8B-4162-9399-EDC8A787E10E Q35637089-8388C664-4352-4C9F-9B24-ED58814BC26D Q35818125-42C97C63-1CB9-40A7-9D98-B97B563AB4A8 Q35822337-4470141D-A6FC-4101-B5B6-78AF88500288 Q35894385-9BB25DF6-CF53-4335-B143-CE4A1B9FF800 Q36015202-8E1F7193-00F7-4551-A35E-AEEC7CE9F65A Q36040510-6C6EC912-D943-4AB2-891A-98AF89E00A77 Q36273603-36504CA8-4B4D-4745-A24B-7BB13E470886 Q36394670-C3650356-2176-494B-806F-E766843D649C Q36480583-32D219B7-43DC-48B2-A6B9-9A4FE46B388C Q36765305-781C4D26-7097-4AFD-9A00-CE13BBF0B1F1 Q37124547-2F500708-7ACA-4B6E-BFB7-61C93D4967F5 Q37148001-E4C793A5-FDE5-4859-A8AA-0177F06AE2F5 Q37609839-7A74709B-0A1F-4FDF-8FEC-0D0BEB81E6CB Q37898029-38BBC697-33BB-41CD-9EF4-C4CE07092C5C Q37917591-38B48B3A-EB39-42CC-A5B5-64E43A7470C4 Q37928593-E1FDED2D-F084-4496-854E-25C37F009BE0 Q38017575-54E15DA9-BA88-4F7F-9F73-82D7C27CC7B2 Q38030196-F88C1E10-83BF-4EDB-86A2-8E4BC8C911F4

P2860

Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.

http://www.wikidata.org/entity/Q30499307

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Lentiviral vector design and i ...... ges of cellular reprogramming.

@ast

Lentiviral vector design and i ...... ges of cellular reprogramming.

@en

type

label

Lentiviral vector design and i ...... ges of cellular reprogramming.

@ast

Lentiviral vector design and i ...... ges of cellular reprogramming.

@en

prefLabel

Lentiviral vector design and i ...... ges of cellular reprogramming.

@ast

Lentiviral vector design and i ...... ges of cellular reprogramming.

@en

P1433

Q30499307-3A1C22A4-0EF9-4B24-A992-C01D46BE1F24

P1476

Q30499307-5A76CD7E-3F1B-4E23-BD19-C5B854EA1C50

P2093

Q30499307-1D76465F-65E9-491E-9098-D65C0444351F

Q30499307-65B457BC-3717-40FB-94AC-449B05A4C5EB

Q30499307-6A30B0DE-2DB0-4D94-805A-E4919CFE273F

Q30499307-A60CF02F-B3E5-4E70-9BDD-24A3CADD42C8

Q30499307-AB6A62C5-2C14-4050-8F00-440BF921ED12

Q30499307-B96692A9-526A-4182-8F92-990802046EEE

Q30499307-C13ECA9E-13BC-42C2-84CB-AD19BAE4770A

P2860

Q30499307-08559A7F-95DB-4515-8D44-ABE6E5DDF68F

Q30499307-0D909B56-2051-49B9-B8B0-A53D227D9F9B

Q30499307-0EB24FF8-8246-4091-B3D1-B0075C70D377

Q30499307-0F1DA363-D0C1-4AFB-B875-EB244C4C4165

Q30499307-111F6D08-572D-4138-9BBC-EE5DC8A66968

Q30499307-133517DB-73E4-4D52-A02B-D0E872E8D175

Q30499307-14519C70-0FEF-4760-B1E6-BC35B62BDB56

Q30499307-16CDD3CD-94E1-4B2A-BFA9-ADEE044729A0

Q30499307-1A7F9867-B47C-4BBA-A785-825DFE1532BC

Q30499307-1CA0D452-9250-4B39-A3F5-BD3003675EC1

P304

Q30499307-9DA2B050-ABD1-495D-97B0-12668FE49A4E

P31

Q30499307-9D2747F7-ECF2-4F9B-B5BF-F6CD7D21487D

P356

Q30499307-BB22D145-8602-4E9B-AD97-A1D5E068D7C1

P433

Q30499307-177AEDF1-875F-4D59-9A66-B04D0EC4BDA2

P478

Q30499307-51CFC21F-B9AE-4C55-AC38-FA1DF46E89D1

P50

Q30499307-0B8874F9-6BD3-49D2-BFFD-79CE15723416

Q30499307-2E0D320A-CBB1-4A24-8E5B-E5524FC34897

Q30499307-445AC98D-5AAC-4E2B-8BAA-A05633E8B63F

Q30499307-6284244E-C85B-4978-B1C9-4CB3E1B35BB1

Q30499307-681CC71D-DC9A-4DD7-9A30-2C98BEA94BEC

Q30499307-A1CB3135-58C8-4D66-98FC-9070E143B292

P577

Q30499307-9C0CB96D-8D09-40B2-AAEA-024A1459F414

P5875

Q30499307-AC52C9C4-4942-4E8B-BFE1-8FD8EE585F46

P698

Q30499307-4123DF8E-20E0-4324-A1BC-BEA70A3C0D21

P932

Q30499307-D7B03875-14F0-459C-8D60-9D67FF6AFD49

P356

P1433

Molecular Therapy

P1476

Lentiviral vector design and i ...... ages of cellular reprogramming

@en

P2093

Adam A Filipczyk

http://www.w3.org/2001/XMLSchema#string

Axel Schambach

http://www.w3.org/2001/XMLSchema#string

Christopher Baum

http://www.w3.org/2001/XMLSchema#string

Eva Warlich

http://www.w3.org/2001/XMLSchema#string

Johannes Kuehle

http://www.w3.org/2001/XMLSchema#string

Melanie Galla

http://www.w3.org/2001/XMLSchema#string

Tobias Maetzig

http://www.w3.org/2001/XMLSchema#string

P2860

Disease-specific induced pluripotent stem cells

Direct cell reprogramming is a stochastic process amenable to acceleration

Induced pluripotent stem cell lines derived from human somatic cells

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

Human induced pluripotent stem cells free of vector and transgene sequences

Generation of mouse induced pluripotent stem cells without viral vectors

Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds

A third-generation lentivirus vector with a conditional packaging system

P304

782-789

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2010.314

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Martijn Brugman

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49802732

http://www.w3.org/2001/XMLSchema#string

P698

21285961

http://www.w3.org/2001/XMLSchema#string

P932

3070104

http://www.w3.org/2001/XMLSchema#string